The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Racial and ethnic disparities in hematologic malignancies
Open accessAbstract
Racial and ethnic disparities in patients with solid malignancies have been well documented. Less is known about these disparities in patients with hematologic malignancies. With the advent of novel chemotherapeutics and targeted molecular, cellular, and immunologic therapies, it is important to identify differences in care that may lead to disparate outcomes. This review provides a critical appraisal of the empirical research on racial and ethnic disparities in incidence, survival, and outcomes in patients with hematologic malignancies. The review focuses on patients with acute myeloid leukemia, acute lymphocytic leukemia, multiple myeloma, non-Hodgkin lymphoma, Hodgkin lymphoma, myeloproliferative neoplasms, and myelodysplastic syndrome. The review discusses possible causes of racial and ethnic disparities and also considers future directions for studies to help decrease disparities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Significant racial and ethnic disparities in the incidence and survival of hematologic malignancies have also been documented [51,52].”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Racial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers, V. L. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.5.334 · Cited by 953
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Tammemägi, M. C. (2005) · JAMA · doi:10.1001/jama.294.14.1765 · Cited by 428
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer
Hamel, L., Penner, L., Albrecht, T., Heath, E., Gwede, C., & Eggly, S. (2016) · Cancer Control: Journal of the Moffitt Cancer Cente · doi:10.1177/107327481602300404 · Cited by 426
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Waxman, A. J., Mink, P. J., Devesa, S. S., Anderson, W. F., Weiss, B. M., Kristinsson, S. Y., McGlynn, K. A., & Landgren, O. (2010) · Blood · doi:10.1182/blood-2010-07-298760 · Cited by 411
Cited by
Sorted by citations
Items 101–168 of 168
Hantel, A., Blackstone, E. C., Revette, A. C., Roberts, J. E., Mims, A. S., DeAngelo, D. J., Lathan, C. S., & Abel, G. A. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf241 · Cited by 3
Expert recommendations for the conduct and appraisal of qualitative research in haematology
Ananth, P. J., Porter, J. S., Boggs, J., Collins, G. S., Williamson, F. A., Bakshi, N., Hankins, J. S., Johnson, L., Elk, R. A., Graetz, D. E., et al. (2026) · The Lancet Haematology · doi:10.1016/s2352-3026(25)00321-7 · Cited by 3
Lawrence, J. A., Jahn, J. L., Shi, J., Himmelstein, K. E. W., Feldman, J. M., Linos, N., & Bassett, M. T. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae444 · Cited by 3
Cheung, C. Y., Tang, A. H. C., Wong, Y. T., Chan, G. S. W., & Tang, S. C. W. (2021) · Nephrology · doi:10.1111/nep.13876 · Cited by 3
Alves-Hanna, F. S., da Silva, F. R. P., Pereira, D. S., Leal, A. L. A. B., Magalhães-Gama, F., & Costa, A. G. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2382503 · Cited by 3
Shah, N. N., Rockwell, B., Kazemi, M., Peeke, S. Z., Bachier‐Rodriguez, L., Sica, R. A., Goldfinger, M., Kornblum, N. S., Braunschweig, I., Shastri, A., et al. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1808211 · Cited by 3
Winestone, L. E. (2022) · Blood · doi:10.1182/blood.2022015433 · Cited by 3
Sciberras, P., Cromie, K., Radford, A. R., Glaser, A., Feltbower, R. G., & Hughes, N. (2024) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2024.0124 · Cited by 2
Valcarcel-Valdivia, B., Cantillo, A. M., Rivarola, S. G., Stemmelin, G. R., Arrua, M. E. E., Glasenapp, A. V., Quiroz, A. R., Warley, F., Orlova, M., Vasquez, J. F., et al. (2025) · Blood Global Hematology · doi:10.1016/j.bglo.2025.100002 · Cited by 2
Elmariah, H., & Bolaños‐Meade, J. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-84988-6_5 · Cited by 2
Disparity in hematological malignancies: From patients to health care professionals
Chen, X., Shukla, M., & Fleur-Lominy, S. S. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101169 · Cited by 2
Albrecht, T., Pastva, A. M., Yang, Q. Z., Lee, Y., LeBlanc, T. W., Richardson, D. R., & Bryant, A. L. (2024) · Cancer Nursing · doi:10.1097/ncc.0000000000001408 · Cited by 2
Racial/ethnic disparities: need more work!
Landgren, O. (2017) · Blood · doi:10.1182/blood-2017-08-798546 · Cited by 2
Horn, B. N., Lamba, N., Chellapandian, D., Sunkersett, G., Silva, J. G., Ziga, E. D., Alperstein, W., Joyce, M., Castillo, P., Fort, J. A., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29180 · Cited by 2
Racial Disparities in the Surgical Management of Benign Craniomaxillofacial Bone Lesions
Phillips, S. J., Reategui, A. A., Peck, C. J., Ibrahim, G., Lopez, J., & Steinbacher, D. M. (2021) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000007832 · Cited by 2
Epidemiologic evaluation of clinical outcomes in ethnic minorities with myelodysplastic syndromes
Molina, A., Xiao, L., Ostrom, Q. T., Rosas, L. G., & Greenberg, P. L. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106907 · Cited by 2
Ashouri, K., Ginosyan, A. A., Chu, M., Hom, B. M., Hwang, J. D., Resnick, K., Rahimi, Y., Chaudhary, P. M., Woan, K. V., Siddiqi, I. N., et al. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107501 · Cited by 2
Sick While Black: An Unhealthy Combination
Hoffer, E. P. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.07.017 · Cited by 2
Valcarcel-Valdivia, B., Stemmelin, G. R., Rivarola, S. G., Cantillo, A. M., Beltrán, B., Castro, D., CHIATTONE, C. S., Fischer, T. R. D. C., Nicora, A., Glasenapp, A. V., et al. (2025) · JCO Global Oncology · doi:10.1200/go-24-00605 · Cited by 1
Cusworth, S., Deplano, Z., Denniston, A. K., Burns, D., Nirantharakumar, K., Adderley, N. J., & Chandan, J. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099354 · Cited by 1
Crowder, V., Bankole, A. O., Conklin, J. L., Sawyer, A. S., Holliday, A. M., Fogle, R., Coombs, L. A., Richardson, D. R., Batchelor‐Murphy, M., Beeber, A., et al. (2025) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2025.06.028 · Cited by 1
Reporting and enrollment disparities in hematologic malignancy trials between 2000–2023
Gong, I. Y., Rafinejad‐Farahani, B., Majeed, H., Soto, M. J., Oza, A. M., Ehrlich, T., Lynch, H. F., Guerra, C. E., Lofters, A., Unger, J. M., et al. (2025) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2025.2579735 · Cited by 1
Melo, A., Ahmed, S., Anzuman, M., Allana, S., Kilcoyne, M., Nhim, V., Padilla, O., Dwivedi, A. K., & Eiring, A. M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1703050 · Cited by 1
AML Disparities Across Racial Ancestry Groups: A Spotlight on the NPM1 Mutations
Sanaullah, S. A., Vidi, P., & Pardee, T. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010510 · Cited by 1
Weber, D. M. (2021) · Saber Científico (1982-792X) · doi:10.22614/resc-v9-n2-1377 · Cited by 1
Hematopoietic toxicity in Wistar rats experimentally exposed to cement dust
Owonikoko, M. W., Salami, A. T., Odukanmi, O. A., Emikpe, B. O., & Olaleye, S. B. (2022) · Comparative Clinical Pathology · doi:10.1007/s00580-021-03315-z · Cited by 2
Buriticá, L. M., Ocampo-Medina, M., Ospina, S., Regino, C. A., Palacio, G. V., & Torres, J. D. (2022) · Medicina y Laboratorio · doi:10.36384/01232576.591 · Cited by 1
Leukemia - From Biology to Clinic
Guenova, M. L., & Balatzenko, G. N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100848 · Cited by 1
Yusuf, A. A., & Ibrahim, H. (2023) · Tropical Medicine & International Health · doi:10.1111/tmi.13949 · Cited by 1
Drouin, K., Purol, N., Tarquini, S. J., Burgers, D. E., & Uhl, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-38058-7_16 · Cited by 1
Li, V., Alibhai, S. M. H., Noel, K., Fazelzad, R., Haase, K. R., Mariano, C. J., Durbano, S., Sattar, S., Newton, L. J., Dawe, D. E., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-074191 · Cited by 1
Jiang, J. Y., Li, A., Romero, A., Flowers, C. R., & Nze, C. C. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf180 · Cited by 1
O'Connor, T. E., Lin, C., Roloff, G. W., Zhang, A., Miller, K., Aldoss, I. T., Kopmar, N. E., Dekker, S. E., Gupta, V. K., Jeyakumar, N., et al. (2025) · Bone Marrow Transplantation · doi:10.1038/s41409-025-02693-0 · Cited by 1
Management of Newly Diagnosed Acute Myeloid Leukemia in Older Adults
Gupta, G., & Garg, V. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109700 · Cited by 1
Why does the place where the allogeneic transplant patient calls home matter?
Langston, A. A. (2020) · Cancer · doi:10.1002/cncr.33231
Buitrago-Toro, K., Perdomo, L. C. Á., Leiva, L. M., Chavarro, A. F. M., Castañeda, C. P., & Jiménez-Salazar, S. (2020) · Galicia Clínica · doi:10.22546/58/1930
Maternal Ancestry and Hematological Cancer Risk: Case–Control Study in an Argentinean Population
Cerliani, M. B., Mayordomo, A. C., Dova, A. S., Soarez, J. N., Etcheverry, J. F., Piñero, T. A., Cajal, A. R., Jauk, F., Rivello, H. G., Vaccaro, C. A., et al. (2021) · Personalized Medicine · doi:10.2217/pme-2020-0062 · Cited by 2
Zhang, Y. D., Xu, Z., Qin, T. J., Li, B.-X., Qu, S. Q., Pan, L. J., Jiao, M., & Xiao, Z. (2021) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2021.05.005
McElroy, S., Myers, G. D., & Flatt, T. G. (2023) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002613
Ngwube, A. I., Shah, A. S., Regan, C. M., Suwarno, S., Foote, J. A., Bernaud, V. E., Stahlecker, J., Miller, H., Booth, N. A., Giralt, D., et al. (2023) · doi:10.22541/au.167776745.58738937/v1
Sánchez, A. N. B., & Ordóñez, G. D. B. (2023) · Revista Colombiana de Cancerología · doi:10.35509/01239015.892
Lin, O. M., Shen, M. J., Li, C. I., & Lee, S. J. (2023) · Cancer Causes & Control · doi:10.1007/s10552-023-01730-x
Self-citationShah, A. S., Regan, C. M., Suwarno, S., Foote, J. A., Bernaud, V. E., Stahlecker, J., Miller, H., Booth, N. A., Giralt, D., Salzberg, D. B., et al. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30493
Lee, E., & Rogers, M. (2023) · Essential clinical social work series · doi:10.1007/978-3-031-31650-0_3 · Cited by 1
Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study
Lesegretain, A., Brunner, A. M., Benzohra, A., & Fathi, A. T. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2252123
Guarding the Heart in an Era of “Tachy-CAR-T”
Blue, B. J., Alomar, M., & Locke, F. L. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.11.001
Cui, W., & Finkelstein, J. (2024) · Studies in health technology and informatics · doi:10.3233/shti231106
BS, F. B. J. B. M., & ChB, F. M. L. M. (2024) · doi:10.1002/9781394218615.ch1
Yeyeodu, S. T., Hanafi, D., Webb, K., Laurie, N. A., & Kimbro, K. S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1286979 · Cited by 1
McArthur, E. (2024) · Canadian Oncology Nursing Journal · doi:10.5737/23688076343293
McArthur, E. (2024) · Canadian Oncology Nursing Journal · doi:10.5737/2368807632446343298
Cusworth, S., Deplano, Z., Denniston, A. K., Burns, D., Nirantharakumar, K., Adderley, N. J., & Chandan, J. S. (2024) · medRxiv · doi:10.1101/2024.11.18.24317089
Immanuel, T., Green, T. N., Holmes, A. V., Pi, S., Chien, N., & Kalev‐Zylinska, M. L. (2025) · Blood Global Hematology · doi:10.1016/j.bglo.2025.100006
Thordardottir, T. H., Rodenbach, R. A., Bräuer, M., Hall, A. C., Ward, E. C., Smith, C. B., & Campbell, T. C. (2025) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2025.2500625
Li, V., Alibhai, S. M. H., Haase, K. R., Sattar, S., Newton, L. J., Muhammad, S. S., Santos, B., Suresh, S., Li, J., Sattar, H., et al. (2025) · JCO oncology advances. · doi:10.1200/oa-24-00099
Hematopoietic cell transplantation and cellular therapy
Khan, I., Shah, N. N., & Ulrickson, M. L. (2022) · doi:10.1182/ashsap8.chapter14
Chao, E., Marshalek, J. P., Yashar, D., & Tomassetti, S. (2025) · SAGE Open Medicine · doi:10.1177/20503121251365462
Oral Secondary Malignant Lesions Post-Hematopoietic Stem Cell Transplantation: A Review
de Aguiar, T. M. (2025) · Brazilian Journal of Transplantation · doi:10.53855/bjt.v28i1.705_eng
Lesões Malignas Secundárias Orais Pós-Transplante de Células-Tronco Hematopoiéticas: Uma Revisão
Aguiar, T. (2025) · Brazilian Journal of Transplantation · doi:10.53855/bjt.v28i1.705_port · Cited by 1
Taylor, A. O., Fish, L. J., Herring, K. W., Infield, J., Johnson, K. S., & LeBlanc, T. W. (2026) · Palliative Medicine Reports · doi:10.1177/26892820251403847
Thida, A. M., Nasirikhaneghah, E., Gonsky, J. P., & Chiu, E. (2026) · Inquisiva Open · doi:10.64551/001c.158539
Zhang, Y., & Tian, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1818278
State Policy Variation and Telehealth Use by Oncology Specialists Treating Medicaid Patients
Vichare, A. M., Bodas, M., Luo, Q., Khera, N., Gandhi, A., Shipman, S. A., & Erikson, C. E. (2026) · Telemedicine Journal and e-Health · doi:10.1177/15305627261455444
Immunogenetic risk factors for oncohematological diseases”
Витальевна, К. Е., Pavlova, I. E., Tv, G., & Bubnova, L. N. (2026) · Medical Immunology (Russia) · doi:10.15789/1563-0625-irf-3382
Swaminathan, M., Abbas, H. A., Roth, M., Hildebrandt, M. A. T., Fingrut, W. B., Kadia, T. M., Daver, N. G., Dinardo, C. D., Borthakur, G. M., Jabbour, E. J., et al. (2026) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2026.06.011
Evolution of real-world frontline treatment patterns in multiple myeloma
Lazzaro, A., Nannini, K., Yildirim, C., Huhmann, L., Culnan, J., Corrigan, J. K., Elbers, D. C., Do, N., Brophy, M. T., Munshi, N. C., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2026019843
Temporal trends in relative survival and excess mortality among US adults with lymphoid malignancies
Valcarcel-Valdivia, B., Leautaud, V., Hildebrandt, M. A. T., Rodriguez, M. A., McCurry, D., Shukla, S. A., Cesarman, E., Beltrán, B., Quiñones, P., Castro, D. A., et al. (2026) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djag341
Metadata
- Authors
- Kirtane, K., & Lee, S. J.
- Affiliations
- University of Washington (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-10-12
- Volume
- 130
- Issue
- 15
- Pages
- 1699-1705
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC5639484
- OpenAlex
- W2737749411
- Cited by
- 168
- References
- 52
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 23 · 2023: 24 · 2022: 23 · 2021: 31 · 2020: 16 · 2019: 10 · 2018: 5 · 2017: 1
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- National Institutes of Health
- National Cancer Institute (T32CA009515)
- National Institute on Minority Health and Health Disparities
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- racial and ethnic disparities, hematologic malignancies, acute myeloid leukemia, acute lymphoblastic leukemia, multiple myeloma, non-Hodgkin lymphoma, Hodgkin's disease, myeloproliferative neoplasms, myelodysplastic syndrome, cancer incidence, cancer survival, health disparities
- MeSH terms
- Clinical Trials as Topic, Ethnicity, Humans, Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms, Racial Groups, Health Status Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
